Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
RELATED RESEARCH RESOURCES AND LINKS
ListGraphMap
Displaying 1 - 10 of 62 Projects
Project # Contact PI Funding Organization Fiscal Year
Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in FTLD-TDP
PTCG-21-818270 Peter Ljubenkov Alzheimer's Association 2021
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients with C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)
ADDF-35 Panzara, Michael Alzheimer's Drug Discovery Foundation 2021
Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in Semantic Variant Primary Progressive Aphasia Due to Underlying FTLD-TDP
1R01AG073482-01 LJUBENKOV, PETER ALEXANDER NIA 2021
Cerebral amyloid angiopathy fluid biomarkers evaluation (CAFE)
5R01NS104147-04 VAN NOSTRAND, WILLIAM E. NINDS 2021
Phase 1 Study of a Novel Device Reducing Vascular Contributions to Dementia
PTCG-20-694888 Celermajer, David Alzheimer's Association 2020
Phase 2 study of CNS sGC stimulation in AD with vascular features
PTCG-20-707481 Winrow, Christopher Alzheimer's Association 2020
Highly selective detection of tau oligomers in biological fluids for the diagnosis of Alzheimer's Disease
5R42AG058333-03 VOLLRATH, BEN NIA 2020
Cerebral amyloid angiopathy fluid biomarkers evaluation (CAFE)
5R01NS104147-03 VAN NOSTRAND, WILLIAM E. NINDS 2020
FUS modifying enzymes: a therapeutic target for common sporadic FTLD-FUS type dementia
ARUK-TVPG2018-005 Peter Henry St George-Hyslop Alzheimer's Research UK 2019
Integrative translational discovery of vascular risk factors in aging and dementia
3RF1AG051504-01S3 ERTEKIN-TANER, NILUFER NIA 2019